**Purpose:** Attempts to modulate the wound healing process to minimize scarring remain among the most basic yet difficult challenges facing plastic surgeons. In this study, we focused on a new medical agent that has the potential to modulate the wound healing process to facilitate rapid healing of an incisional dermal wound with minimal scarring. This agent modulates the *neuronal PAS domain 2* (*Npas2*) gene, which is integral to circadian rhythm function. In a previous study, we reported that *Npas2* was associated to some degree in the modulation of wound healing. In this study, we performed high-throughput screening (HTS) to identify the compounds that suppress *Npas2* and accelerate fibroblast migration to the wound site and have analyzed the effect of *Npas2* on fibroblast behavior using one of *Npas2* suppressor molecules on *in vitro and in vivo* wound healing.

**Methods:** Primary fibroblasts were isolated from WT and *Npas2* heterozygous knockouts with reporter gene (*Npas2+/*-) mice. *Npas2+/*- fibroblasts were seeded on 384 plates, treated with 1,120 FDA-approved compounds and we then observed reporter gene expression. We also tested cell migration under the 1,120 compounds using Oris Cell Migration Assay. Then, WT fibroblast behaviors were characterized using scratch tests and floating collagen gel culture under one of hit compounds, named Dwn1. The effects of Dwn1 on fibroblast migration *in vitro* and in the full-thickness dorsal skin punched-out wound healing model *in vivo* were tested.

**Results:** Several hit compounds were discovered to simultaneously suppress *Npas2* and thus increase fibroblast migration. Fibroblasts treated with Dwn1 showed increased cell migration and contraction capabilities relative to untreated FB. Furthermore, gross imaging of Dwn1-treated dermal wounds show statistically significant accelerated wound healing vs non-treated wounds.

**Conclusions:** This study demonstrates that *in vitro* cultures of primary FBs treated with Dwn1 show greater migration and contractility. In addition, dorsal punch wounds treated with Dwn1 show similarly enhanced wound healing versus non-treated models. Our observations suggest that the down-regulation of the *Npas2* gene might contribute to more efficient dermal wound healing. The clinical ramifications of these in vitro findings warrant further investigation.
